Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
boston top stories
deals
3
×
life sciences
national blog main
national top stories
3
×
biotech
roche
alexion pharmaceuticals
alnylam pharmaceuticals
biopharma
boehringer ingelheim
clinical trials
crispr
david walt
diagnostics
dicerna pharamceuticals
duchenne
europe blog main
europe top stories
fda
feng zhang
gene editing
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
illumina
jennifer doudna
jim collins
licensing
m&a
mammoth biosciences
muscular dystrophy
patisiran
rna interference
san francisco blog main
san francisco top stories
sarepta therapeutics
startups
What
gene
3
×
medicines
roche
approval
betting
billion
bio
biopharma
caught
causing
create
crispr
deal
diagnostic
dicerna
disease
diseases
drug
duchenne
editing
eye
fda
fix
heats
hepatitis
high
historic
human
intended
launches
medicine
pay
pharma
pharmaceuticals
producing
protein
puts
race
recently
research
Language
unset
Current search:
gene
×
boston
×
deals
×
" national top stories "
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
